09/10/2019 - Health

Kindly review. Thank you.

KEY POINTS

·        The current outbreak about the resurgence of Ebola, which has now been declared a public health emergency of international concern, has already claimed nearly 2,500 lives.

·        The Ebola crisis has also inspired the creation of important multi-partner initiatives, such as the Coalition for Epidemic Preparedness Innovations, a global alliance dedicated to developing vaccines against emerging infectious diseases.

Need for investing in Vaccines

·        Especially in a country like India, which has a high burden of infectious diseases that can spread rapidly given the density of population investment in vaccination is the need of the hour.

·        By investing in vaccine development, India can create lasting health and economic benefits for its citizens. In fact, vaccines are one of the most cost-effective public health interventions.

·        This corresponds to the investment in human capital formation and further improves the quality of life in the country.

·        A 2016 study of 94 lower-income countries found that, for every dollar invested in vaccination, more than 16 dollars are expected to be saved in healthcare costs, lost wages and lost productivity due to illness and death.

·        Already, there is a significant and exciting progress to develop indigenous vaccines. India is home to mature and successful vaccine production companies, highly respected worldwide.

·        Many vaccines in India’s Universal Immunisation Programme (UIP) are manufactured by Indian companies.

·        Over the last two years, three vaccines produced in India received the WHO’s prequalification—two rotavirus vaccines currently used in India’s UIP, and the world’s first typhoid conjugate vaccine.

·        Since its launch in 2014, the government’s immunisation scheme, Mission Indradhanush, has vaccinated over 33 million children across the country.

·        Additionally, the government and its partners have developed innovations to help reach every child, such as the Electronic Vaccine Intelligence Network (eVIN), which provides real-time information on vaccine stocks in 371 districts.

·        Vaccine research and development, introduction and scale-up requires considerable time, government prioritization, investment and multi-sectoral partnerships. Above all, it requires a sense of urgency.

·        Only if we invest the time and effort today, can we ensure healthy lives for generations to come.

Pls review.thanks

Kindly review.

Kindly review. Thank you